Whalegun
Home

PTC Therapeutics PTCT paid The McManus Group $30K for lobbying in Q4 2023 · Medicare, Health Issues and 1 more issue

Trade details

Type
Lobbying report
Amount
$30,000
Quarter
Q4 2023
Stock
PTC Therapeutics PTCT
Client
PTC Therapeutics
Reported
24/01/20

Up 0.0% from last quarter

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

PTC Therapeutics's other lobbying reports

  • PTC Therapeutics

    LobbyingPTC Therapeutics

    $50K

    Reported 07/20

  • PTC Therapeutics

    LobbyingPTC Therapeutics

    $170K

    Reported 07/20

  • PTC Therapeutics

    LobbyingPTC Therapeutics

    $50K

    Reported 07/05

  • PTC Therapeutics

    LobbyingPTC Therapeutics

    $50K

    Reported 04/20

  • PTC Therapeutics

    LobbyingPTC Therapeutics

    $390K

    Reported 04/20

PTC Therapeutics PTCT paid The McManus Group $30K for lobbying in Q4 2023 · Medicare, Health Issues and 1 more issue | Whalegun